Phillip Brady Hayden, the Chief Financial Officer of $CURI ($CURI), bought 2,000 shares of the company on 12-12-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 5.6%. Following this trade, they now own 38,000 shares of $CURI stock.
$CURI Insider Trading Activity
$CURI insiders have traded $CURI stock on the open market 21 times in the past 6 months. Of those trades, 4 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $CURI stock by insiders over the last 6 months:
- PHILLIP BRADY HAYDEN (Chief Financial Officer) has traded it 3 times. They made 3 purchases, buying 4,343 shares and 0 sales.
- CLINTON LARRY STINCHCOMB (President and CEO) purchased 17,877 shares.
- JONATHAN HUBERMAN has traded it 5 times. They made 0 purchases and 5 sales, selling 170,861 shares.
- MICHAEL NIKZAD has traded it 12 times. They made 0 purchases and 12 sales, selling 349,154 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CURI Hedge Fund Activity
We have seen 23 institutional investors add shares of $CURI stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MANATUCK HILL PARTNERS, LLC added 480,900 shares (+inf%) to their portfolio in Q3 2024
- CWM, LLC added 225,188 shares (+310.7%) to their portfolio in Q3 2024
- HILLSDALE INVESTMENT MANAGEMENT INC. added 125,071 shares (+inf%) to their portfolio in Q3 2024
- WATERFRONT WEALTH INC. removed 97,472 shares (-100.0%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC added 88,396 shares (+inf%) to their portfolio in Q3 2024
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 86,496 shares (+inf%) to their portfolio in Q3 2024
- GEODE CAPITAL MANAGEMENT, LLC added 56,402 shares (+21.2%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
